# GramEye

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/grameye

- Industry: Healthcare IT
- Headquarters: Ibaraki-shi, Japan
- Website: https://grameye.com
- Total disclosed funding: $6.1M
- Latest round: Series B (Nov 20, 2025)
- Investors on record: 7

## About

Based in Osaka, Japan, and founded in 2020, GramEye Inc. develops medical devices that use Gram staining with robotics and deep learning to automate sample handling, process microscopic images, support clinical laboratory operations, and enable consistent analysis across microbiology workflows. In November 2025, GramEye Inc. raised JPY 570 million in series B funding from new investor Beyond Next Ventures with participation from existing investors Samurai Incubate and NES.

The company offers medical devices which automate gram staining along with deep learning and robotics. The firm develops artificial intelligence and robotics technology to resolve the problem of drug-resistant bacteria.

## Funding rounds

- Series B, Nov 20, 2025, $3.7M — Samurai Incubate, Beyond Next Ventures, NES
- Series A, Oct 13, 2023, $2.4M — SMBC Venture Capital, Samurai Incubate, Senshu Ikeda Capital, Deepcore, NES, STATION Ai

## Investors

- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series A
- Samurai Incubate (https://capitalatlas.ai/funds/samurai-incubate) — Series A, Series B
- Senshu Ikeda Capital (https://capitalatlas.ai/funds/senshu-ikeda-capital) — Series A
- Deepcore (https://capitalatlas.ai/funds/deepcore) — Series A
- NES (https://capitalatlas.ai/funds/nes) — Series A, Series B
- STATION Ai — Series A
- Beyond Next Ventures (https://capitalatlas.ai/funds/beyond-next-ventures) — Series B